FDA authorizes Pfizer's COVID-19 vaccine booster

The FDA authorized Pfizer's coronavirus vaccine booster shot for those who are high-risk or aged 65 and older. It comes as the Delta variant surge appears to be peaking nationally, according to researchers advising the CDC.